|
Scandonest LDrug - Scandonest L The trade name of the product as shown on the labeling.
Dosage -
INJECTABLE; INJECTION
Active Ingredient(s) -
Levonordefrin; Mepivacaine Hydrochloride
Strength -
0.05MG/ML;2%
Applicant -
DEPROCO
New Drug Application (NDA) Number -
088388
Product Number -
001
Therapeutic Equivalence (TE) Code -
AP
Approval Date -
Oct 10, 1984
Reference Listed Drug (RLD) -
No
Type -
RX
Applicant Full Name -
Deproco Inc
Scandonest L
Levaquin 500mg Tablet; Oral
Levaquin 750mg Tablet; Oral Levofloxacin 750mg Tablet; Oral Orlaam 10mg/ml Concentrate; Oral Arestocaine Hcl W/ Levonordefrin 0.05mg/ml;2% Injectable; Injection Carbocaine W/ Neo-cobefrin 0.05mg/ml;2% Injectable; Injection Isocaine Hcl W/ Levonordefrin 0.05mg/ml;2% Injectable; Injection Mepivacaine Hcl W/ Levonordefrin 0.05mg/ml;2% Injectable; Injection Polocaine W/ Levonordefrin 0.05mg/ml;2% Injectable; Injection Scandonest L 0.05mg/ml;2% Injectable; Injection NewDrugInformation |